Participation in Procurement of Tissue, Serum, Plasma, Cell Bank, DNA and RNA Samples, and Urine for Biological Studies Related to Prostate Cancer and Prostate Cancer Treatment Follow Up

Lead Sponsor

Mayo Clinic

Age

18 - No limit years

Sex

MALE

Healthy Volunteers

No

•1. Informed consent explained and signed prior to any study related procedures.
•2. Age ≥18 years
•3. Eastern Cooperative Oncology Group (ECOG) performance status of 2 or better, or Karnofsky performance of 60% or better.
•4. Histologically confirmed adenocarcinoma of the prostate within 10 years of study entry.
•5. Willingness to return to Mayo Clinic Rochester for follow-up or participate in mail-in PSA processing.
•6. Must be disease-free from a previous diagnosis of cancer for a period of time = 5 years excluding cutaneous malignancies of squamous cell or basal cell carcinoma.

•1. Life expectancy \< 5 years.
•2. Inability to return to Mayo Rochester for follow-up appointments, sera, and urine collection per protocol.
•3. Previous or a concurrent diagnosis of cancers other than basal cell or invasive squamous cell carcinoma of skin within the past 5 years.

Related studies

NCT06787053 · Bladder (Urothelial, Transitional Cell) Cancer, Prostate Cancer

NCT07580196 · Prostate Cancer

NCT06616155 · Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, and more

NCT07124000 · Adenocarcinoma (NOS), Anal Cancer, and more

NCT07181122 · Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)